As of 28 February, 2020

• No staff infected or suspected in TÜV Rheinland Greater China.
• Our laboratories in Greater China have resumed business from this week with 90% of operation capacity.
• 25 offices in Greater China Region have opened.
• As of February 28, TÜV Rheinland Greater China conducted a series of online seminars and introduced the industry's first aerosol filtering protection standard and various new services in response to the epidemic.

In order to fully support customers to conduct business normally during the epidemic and better assist enterprises to reduce the impact of the epidemic on production, TÜV Rheinland Greater China provides customers with convenient and high-quality services through online communication, including online seminars and online courses to BMW Brilliance, Xiaopeng Automobile, Huawei, Beijing Benz and Midea through the online platforms.

In response to the many new needs arising from the epidemic, TÜV Rheinland Greater China has launched a series of new services in a timely manner, for example, we developed the industry's first aerosol filtering protection performance standard 2PfG CH0005: 2020-02 during the epidemic period. February 25, Geely Auto, China's leading automobile brand, became the first company to obtain TÜV Rheinland's Aerosol filtering protection China-mark certification.

In addition, the Guidelines for the Implementation of Virus Infectious Prevention and Control Measures in Manufacturing Plants and the Key Points for Review of Viral Infectious Prevention and Control in Industrial Manufacturing Industries have also been compiled. These two materials have been adopted by the Dalian Industry and Information Bureau and provided to enterprises in the city as Reference for carrying out epidemic prevention and control work.

Besides leveraging the strength of technical capabilities in the field of testing and certification during epidemic, TÜV Rheinland Greater China employees also actively show their empathy and donated more than RMB 320,000. It will be delivered to the Zhongnan Hospital of Wuhan University through the China Youth Development Foundation for the treatment of COVID-19 patients and the purchase of anti-epidemic supplies such as reagents and protective equipment.